183 related articles for article (PubMed ID: 26134215)
1. Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.
Ikoma Y; Sasaki T; Kimura Y; Seki C; Okubo Y; Suhara T; Ito H
Ann Nucl Med; 2015 Oct; 29(8):697-708. PubMed ID: 26134215
[TBL] [Abstract][Full Text] [Related]
2. Quantification and discriminative power of
Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
[TBL] [Abstract][Full Text] [Related]
3. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
[TBL] [Abstract][Full Text] [Related]
4. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
[TBL] [Abstract][Full Text] [Related]
5. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
Seki C; Ito H; Ichimiya T; Arakawa R; Ikoma Y; Shidahara M; Maeda J; Takano A; Takahashi H; Kimura Y; Suzuki K; Kanno I; Suhara T
Ann Nucl Med; 2010 May; 24(4):249-60. PubMed ID: 20364374
[TBL] [Abstract][Full Text] [Related]
8. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
9. Age-related decline in dopamine transporter in human brain using PET with a new radioligand [¹⁸F]FE-PE2I.
Shingai Y; Tateno A; Arakawa R; Sakayori T; Kim W; Suzuki H; Okubo Y
Ann Nucl Med; 2014 Apr; 28(3):220-6. PubMed ID: 24385293
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
Bang JI; Jung IS; Song YS; Park HS; Moon BS; Lee BC; Kim SE
Nucl Med Biol; 2016 Feb; 43(2):158-64. PubMed ID: 26872440
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
[TBL] [Abstract][Full Text] [Related]
12. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.
Nye JA; Votaw JR; Bremner JD; Davis MR; Voll RJ; Camp VM; Goodman MM
Nucl Med Biol; 2014 Mar; 41(3):217-22. PubMed ID: 24533985
[TBL] [Abstract][Full Text] [Related]
13. Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.
Yaqub M; Boellaard R; van Berckel BN; Ponsen MM; Lubberink M; Windhorst AD; Berendse HW; Lammertsma AA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1397-406. PubMed ID: 17191076
[TBL] [Abstract][Full Text] [Related]
14. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
[TBL] [Abstract][Full Text] [Related]
15. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter imaging with [
Jakobson Mo S; Axelsson J; Jonasson L; Larsson A; Ögren MJ; Ögren M; Varrone A; Eriksson L; Bäckström D; Af Bjerkén S; Linder J; Riklund K
EJNMMI Res; 2018 Nov; 8(1):100. PubMed ID: 30443684
[TBL] [Abstract][Full Text] [Related]
17. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
Varrone A; Steiger C; Schou M; Takano A; Finnema SJ; Guilloteau D; Gulyás B; Halldin C
Synapse; 2009 Oct; 63(10):871-80. PubMed ID: 19562698
[TBL] [Abstract][Full Text] [Related]
18. Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies.
Varrone A; Gulyás B; Takano A; Stabin MG; Jonsson C; Halldin C
Nucl Med Biol; 2012 Feb; 39(2):295-303. PubMed ID: 22033024
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
[TBL] [Abstract][Full Text] [Related]
20. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
